Richard Petrella, MD
Interventional Cardiology · Statesboro, GANPI 1902800972
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Abiomed at 27.2% of the total. Reporting peaked in 2019 at $551 and has fallen 74.9% since, to $138 in 2025. That places this record below the midpoint for interventional cardiology clinicians in GA, where the typical reported total is $7,640.
Across 69 payments — averaging $24.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$460
- Boston Scientific$442
- Abbott$227
- Edwards Lifesciences$113
- Angiodynamics, Inc.$100
- Livanova USA, Inc.$97
- plus $253 from 9 others
Across 13 payments — averaging $3270.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Contego Medical, Inc$43K
What the payments were for
- Food & beverage$1,690100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 19 | $460 |
| Boston Scientific | 31 | $442 |
| Abbott | 5 | $227 |
| Edwards Lifesciences | 1 | $113 |
| Angiodynamics, Inc. | 1 | $100 |
| Livanova USA, Inc. | 1 | $97 |
| Cook Medical LLC | 1 | $69 |
| Baxter Healthcare | 2 | $33 |
| Novartis | 2 | $31 |
| BD | 1 | $26 |
| Medtronic | 1 | $26 |
| Amarin Pharma, Inc. | 1 | $20 |
| Acist Medical Systems, Inc. | 1 | $20 |
| Amgen | 1 | $15 |
| Inari Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$125
- GENERAL GUIDEWIRES$119
- SAPIEN 3 Ultra RESILIA$113
How this compares
$1,690 in reported general payments places this provider in the 10th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 99 | $87,141 |
| EntrestoSacubitril/Valsartan | 59 | $48,790 |
| XareltoRivaroxaban | 31 | $25,316 |
| JardianceEmpagliflozin | 25 | $24,755 |
| Prasugrel Hcl | 36 | $6,032 |
| Spironolactone-HctzSpironolact/Hydrochlorothiazid | 53 | $2,623 |
| Atorvastatin Calcium | 174 | $1,863 |
| Metoprolol Succinate | 167 | $1,625 |
| ClopidogrelClopidogrel Bisulfate | 121 | $1,371 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 37 | $1,235 |
| Spironolactone | 157 | $1,226 |
| Rosuvastatin Calcium | 83 | $950 |
| Amiodarone Hcl | 46 | $786 |
| Bumetanide | 25 | $603 |
| Ezetimibe | 43 | $576 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $31 | $48,79059 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 10th percentile of 218 interventional cardiology providers in Georgia.
Other interventional cardiology in Statesboro
- Kendall GriffithStatesboro$21K
- William NicholsonAtlanta$1000K
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
- Salvatore ManninoMarietta$275K
- Megan CoylewrightCalhoun$271K
- Paul GuichardMarietta$260K
- Adam GreenbaumAtlanta$238K
- Wissam JaberAtlanta$222K
- Mudassar AhmedGainesville$193K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.